We acted as a legal advisor when Oivauni Oy sold the majority of its shares to Coronaria Oy on 3 April 2018. Following the arrangement, Coronaria and Oivauni offer services for people with sleep problems. The customer base includes private customers, corporate customers and the public sector.

Oivauni Oy was established in 2007. It specializes in the treatment of sleep disorders. The company’s turnover in 2017 was €1 million. Oivauni Oy has three sleep clinics, located in Helsinki, Tampere and Kuopio.

Global law firm White & Case LLP has advised independent, privately-held investment company Cobepa, and the other shareholders of Exclusive France Holding SAS, on the €1.3 billion sale of Exclusive Group to London-based international investment firm Permira.

"We advised Cobepa on the acquisition of Exclusive Networks in 2015, and have now advised the shareholders of Exclusive Group on this strategic transaction which will help propel the business to the next level," said Brussels-based White & Case partner Thierry Bosly, who led the Firm's deal team.

Ropes & Gray has advised Ares Management on the sale of its portfolio company Cordium - a leading provider of governance, risk and compliance services - to ACA Compliance Group, a US-headquartered leading provider of risk management and technology solutions that focus on regulatory compliance, performance, financial crime, and cybersecurity. The transaction is expected to close in the summer, subject to regulatory approvals. The financial terms of the transaction have not been disclosed.

Willkie represents Impala in the sale of its majority stake in the French removable office partitions specialist Clestra Hauserman.

Willkie advised Impala on the sale of its majority stake in the French removable office partitions specialist Clestra Hauserman, which was held through its subsidiary Impala Industries since 2013. Clestra Hauserman employs 660 people worldwide, including 390 in France, primarily in Illkirch near Strasbourg (270 employees). It generates €150 million in turnover.

Freshfields Bruckhaus Deringer LLP (‘Freshfields’) is advising GCL Holdings LP S.à.r.l., an entity ultimately controlled by aPriori Capital Partners LP and co-invested by Melville S.r.l. (‘Melville’), on the sale of Guala Closures (‘Guala’). Melville is controlled by NB Renaissance Partners Holdings S.à.r.l., a wholly owned subsidiary of NB Renaissance Partners, which is a partnership managed by Neuberger Berman Group.

Gilbert + Tobin is pleased to have advised the ASX-listed AMA Group Limited (AMA Group) on two transactions:

    the proposed demerger of its Automotive Component, Accessory and Procurement Business; and
    the proposed acquisition of the post-demerger AMA Group and its remaining vehicle panel repairs business by The Blackstone Group, for an enterprise value of A$508 million.

The international law firm BEITEN BURKHARDT has advised the family owners of Hanns Glass GmbH & Co. KG on the sale of all its shareholdings to Freudenberg Group. It was agreed not to disclose the purchase price.

Hanns Glass GmbH & Co. KG was founded in the 1930s and has approx. 300 employees at three sites in Germany and the Czech Republic. A previous family enterprise, the company is considered a major manufacturer of car carpets and floor mats in Germany.

Global law firm Norton Rose Fulbright has advised the Wu family, founders of Nature’s Care, on one of the largest private equity investments so far in 2018 to a Chinese consortium.

The consortium, made up of China Jianyin Investment Ltd. (JIC) and Tamar Alliance Partners Fund I, L.P. (Tamar), has entered into a binding agreement to acquire a majority share of Nature’s Care. The Wu family will continue to hold shares in this leading manufacturer and wholesaler of vitamins, supplements and skin care products.

An Orrick Paris team advised Alan, Europe’s first digital health insurance company, in its €23 million series A financing – the most ever raised by a French Insurtech company. The round was led by Index Ventures, with participation by Open CNP, Partech, p3VC and Xavier Niel. This series A follows a $12 million seed round closed at the end of 2016; the company was founded earlier that year.

A cross-border team of Orrick lawyers in Germany and France is advising German/Canadian TVM Capital Life Science, its Austrian portfolio company Biovertis AG, and German subsidiary Morphochem AG on the acquisition of Biovertis and Morphochem by French biotech firm Deinove (listed on Euronext Growth, Paris).